Literature DB >> 12576620

Chancroid: clinical manifestations, diagnosis, and management.

D A Lewis1.   

Abstract

Chancroid is a sexually transmitted disease (STD) caused by the Gram negative bacterium Haemophilus ducreyi and is characterised by necrotising genital ulceration which may be accompanied by inguinal lymphadenitis or bubo formation. H ducreyi is a fastidious organism which is difficult to culture from genital ulcer material. DNA amplification techniques have shown improved diagnostic sensitivity but are only performed in a few laboratories. The management of chancroid in the tropics tends to be undertaken in the context of syndromic management of genital ulcer disease and treatment is usually with erythromycin. A number of single dose regimens are also available to treat H ducreyi infection. Genital ulceration as a syndrome has been associated with increased transmission of human immunodeficiency virus (HIV) infection in several cross sectional and longitudinal studies. Effective and early treatment of genital ulceration is therefore an important part of any strategy to control the spread of HIV infection in tropical countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576620      PMCID: PMC1744597          DOI: 10.1136/sti.79.1.68

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  46 in total

1.  Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification.

Authors:  F A Plummer; M A Wainberg; P Plourde; P Jessamine; L J D'Costa; I A Wamola; A R Ronald
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

2.  Transport media for Haemophilus ducreyi.

Authors:  Y Dangor; F Radebe; R C Ballard
Journal:  Sex Transm Dis       Date:  1993 Jan-Feb       Impact factor: 2.830

3.  Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.

Authors:  K S MacDonald; D W Cameron; L D'Costa; J O Ndinya-Achola; F A Plummer; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

4.  Accuracy of clinical diagnosis of genital ulcer disease.

Authors:  Y Dangor; R C Ballard; F da L Exposto; G Fehler; S D Miller; H J Koornhof
Journal:  Sex Transm Dis       Date:  1990 Oct-Dec       Impact factor: 2.830

5.  Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men.

Authors:  D W Cameron; J N Simonsen; L J D'Costa; A R Ronald; G M Maitha; M N Gakinya; M Cheang; J O Ndinya-Achola; P Piot; R C Brunham
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

6.  Development of the polymerase chain reaction for diagnosis of chancroid.

Authors:  L Chui; W Albritton; B Paster; I Maclean; R Marusyk
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

Authors:  F A Plummer; J N Simonsen; D W Cameron; J O Ndinya-Achola; J K Kreiss; M N Gakinya; P Waiyaki; M Cheang; P Piot; A R Ronald
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

8.  Ceftriaxone no longer predictably cures chancroid in Kenya.

Authors:  M Tyndall; M Malisa; F A Plummer; J Ombetti; J O Ndinya-Achola; A R Ronald
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

Review 9.  Biology of Haemophilus ducreyi.

Authors:  W L Albritton
Journal:  Microbiol Rev       Date:  1989-12

Review 10.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  19 in total

1.  Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Authors:  Robert A Fulcher; Leah E Cole; Diane M Janowicz; Kristen L Toffer; Kate R Fortney; Barry P Katz; Paul E Orndorff; Stanley M Spinola; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results from a random sample of Mexico City pharmacy attendants.

Authors:  A N Turner; C Ellertson; S Thomas; S García
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

3.  Putative vaccine candidates and drug targets identified by reverse vaccinology and subtractive genomics approaches to control Haemophilus ducreyi, the causative agent of chancroid.

Authors:  Alissa de Sarom; Arun Kumar Jaiswal; Sandeep Tiwari; Letícia de Castro Oliveira; Debmalya Barh; Vasco Azevedo; Carlo Jose Oliveira; Siomar de Castro Soares
Journal:  J R Soc Interface       Date:  2018-05       Impact factor: 4.118

4.  Suppurative lymphadenitis.

Authors:  Iain P Fraser
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

5.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

6.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

7.  Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.

Authors:  William G Fusco; Neelima R Choudhary; Shelley M Stewart; S Munir Alam; Gregory D Sempowski; Christopher Elkins; Isabelle Leduc
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

8.  Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid.

Authors:  Isabelle Leduc; William G Fusco; Neelima Choudhary; Patty A Routh; Deborah M Cholon; Marcia M Hobbs; Glen W Almond; Paul E Orndorff; Christopher Elkins
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

Review 9.  Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults.

Authors:  Laura Romero; Cesar Huerfano; Carlos F Grillo-Ardila
Journal:  Cochrane Database Syst Rev       Date:  2017-12-11

10.  Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

Authors:  William G Fusco; Christopher Elkins; Isabelle Leduc
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.